Status:
ACTIVE_NOT_RECRUITING
Fibromyalgia and Sexual Functıonal Dısorder and Sexual Therapy
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Fibromyalgia
Sexual Dysfunction
Eligibility:
FEMALE
15-49 years
Phase:
NA
Brief Summary
investigators aim to re-evaluate the findings of Fibromyalgia in patients whose FSFI scores return to normal levels after sexual therapy, by identifying patients with sexual dysfunction according to t...
Detailed Description
Apart from routine Fibromyalgia treatments, investigators think that Fibromyalgia patients should be evaluated in detail in terms of sexual dysfunction, and better results will be obtained by adding s...
Eligibility Criteria
Inclusion
- Follow-up with a diagnosis of fibromyalgia
- Reproductive age (15-49 years)
- Women with sexual dysfunction (FSFI score \< 26.55)
Exclusion
- Women Wıth Ibromyalgıa Wıthout Sexual Dysfunction
- Women Wıth A Score Greater 26.55 Wıthout Therapy
Key Trial Info
Start Date :
February 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 14 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05272345
Start Date
February 14 2022
End Date
December 14 2025
Last Update
July 18 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Acıbadem University Atakent Hospital, Department of Obstetrics and Gynecology,
Istanbul, Turkey (Türkiye)
2
Pınar Kadiroğulları
Istanbul, Turkey (Türkiye)